High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer. (Q48887166)
Jump to navigation
Jump to search
scientific article published on 9 October 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer. |
scientific article published on 9 October 2008 |
Statements
High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer (English)
S Ropert
J Alexandre
9 October 2008
1 reference
1 reference
1 reference
1 reference
1 reference